Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Blending classic London heritage with modern brewing methods to create innovative styles of beer. Anspach & Hobday is a multi-award winning brand that sells its products in UK retailers and exports to 11 countries worldwide in various containers such as kegs, bottles, casks and more recently, cans. Sales rose from £195k in 2017 to £249k in 2018, a YoY growth of 50%.
Anspach & Hobday is nearing its capacity and is raising funds to increase production threefold and extend their taproom to meet demand. In addition, the company is planning to expand its range of beers and the number of retailers listing their products.
days to go:
Expired
investment:
£526,250
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
days to go:
Expired
investment:
£894,056
Cheran's Bakery, based in Kent, specializes in crafting sumptuous sweet treats available online and at their expanding chain of five stores. With sales exceeding £1.2 million since inception, they create indulgent and creatively packaged products, baked daily for maximum freshness and luxury. Their high-quality, visually appealing shop designs and 'Instagrammable' offerings have attracted over 24,000 social media followers, amplifying brand recognition, while their focus on delivering exceptional customer experiences fosters word-of-mouth promotion.
days to go:
Expired
investment:
£325,482
Kestrl is a mobile app based on the principles of Islamic banking. It aims to cater to the over 1.9 million British Muslim community to invest in the UK in line with their religious beliefs. Consumers can avail a host of financial services from finding interest-free savings accounts to taking out a mortgage. The company raised a £135,000 pre-seed round from C-level Islamic banking professionals in January 2020. It also launched its application on Google Playstore and App store in September 2020. Kestrl is working on launching an equity-based home purchase product soon. It also aspires to expand to Malaysia/Indonesia by white labelling with established retail banks and utilising its 'inside knowledge' of the region. It will use 39% of the investment towards platform up-gradation and tech team expansion, 20% towards hiring personnel across various departments, 19% for maintaining agency license fees and acquiring its own regulatory permissions, 8% in marketing, and 14% towards ancillary costs.
days to go:
Expired
investment:
£194,502
